Canna~Fangled Abstracts Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination Review Biomedicines. 2022 Feb 24;10(3):539. doi: 10.3390/biomedicines10030539. Victor Longoria 1, Hannah Parcel 1, Bameelia Toma 1, Annu Minhas 1, Rana Zeine 2 Affiliations expand PMID: 35327341…Freedom WaresFebruary 24, 2022
For Your Consideration... Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice. Inflammopharmacology. 2018 Oct 5. doi: 10.1007/s10787-018-0536-3. Gallily R1, Yekhtin Z2. Author information Abstract Multiple sclerosis…Freedom WaresOctober 5, 2018
Canna~Fangled Abstracts Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis. Neuropharmacology. 2018 Aug 29. pii: S0028-3908(18)30597-5. doi: 10.1016/j.neuropharm.2018.08.038. Manterola A1, Bernal-Chico A1, Cipriani R2, Ruiz…Freedom WaresAugust 29, 2018
Canna~Fangled Abstracts Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis. 2015 Dec;19(24):4906-4919. Giacoppo S1, Soundara Rajan T, Galuppo M, Pollastro F, Grassi G, Bramanti P, Mazzon E. Author information Abstract OBJECTIVE:…Freedom WaresDecember 19, 2015